Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate

This study is ongoing, but not recruiting participants.

Study NCT00510354 Information provided by Novartis

First Received: July 31, 2007 Last Updated: February 8, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	May 2009 (Final data collection date for primary outcome measure)